Effect of Imatinib Mesylate in a Patient with a Metastatic Gastrointestinal Stromal Tumor with a c-kit Mutation in Exon 11

By Kubota Keisuke   Katayama Atom   Takeshita Yutarou   Nozaki Koji   Ueda Tetsuya   Imamura Kazuhiro   Hiki Naoki   Nomura Sachiyo   Kaminishi Michio   Mafune Ken-Ichi  

Digestive Diseases and Sciences, Vol. 52, Iss. 7, 2007-07 ,pp. : 1725-1729

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Follow-Up Outcome of Imatinib Mesylate Treatment for Recurrent and Unresectable Gastrointestinal Stromal Tumors

By  

Digestion, Vol. 87, Iss. 1, 2013-01 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

A case report of giant esophageal gastrointestinal stromal tumor surgically resected after preoperative imatinib treatment

By Kobayashi Hiroyuki  

Esophagus, Vol. 8, Iss. 2, 2011-06 ,pp. : 119-124

Springer Publishing Company

Access to resources Recommend Favorite

Successful resection of a giant recurrent gastrointestinal stromal tumour with imatinib mesylate as neoadjuvant therapy

By Yu Ji-Ren   Yang Xiao-Jun   Yang Wei-Li   Gao Yuan   Zhang Qing  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 9, 2007-01 ,pp. : 1138-1140

Informa Healthcare

Access to resources Recommend Favorite

A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients

By Sawaki Akira   Yamao Kenji   Nakamura Tsuneya   Suzuki Takashi   Okubo Kenji   Hara Kazuo   Kawai Hiroki   Yamamura Yoshitaka   Ito Seiji   Mochiduki Yoshinari   Ohno Ryuzo  

Journal of Gastroenterology, Vol. 39, Iss. 4, 2004-04 ,pp. : 329-333

Springer Publishing Company

Access to resources Recommend Favorite